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Chylous ascites (CA) is an infrequent postoperative complication of abdominal surgery in the pediatric
population. Herein we report a case of CA following Kasai portoenterostomy for biliary atresia which was
treated with fasting, parenteral nutrition, and intravenous octreotide. We also review the current liter-
ature for CA following biliary procedures in children.
 2013 Elsevier Inc. Open access under CC BY-NC-ND license. Chylous ascites (CA) is an infrequent postoperative complica-
tion in the pediatric population following abdominal and retro-
peritoneal procedures. In the last 30 years, fewer than 50 cases
have been reported. Most cases occurred following procedures for
Wilms tumor [1e3] and neuroblastoma [4e8], while a handful of
cases have also been reported following Nissen fundoplication
[9,10], repair of congenital diaphragmatic hernia [11,12], and liver
resection or transplant [13e15]. Only one case of CA following a
Kasai procedure [16] and three others following choledochal cyst
excision [17e19] have been reported to date. Herein we report a
case of CA following Kasai portoenterostomy which was refractory
to initial therapy and required a prolonged treatment course. We
also compare and review the other cases of CA following pediatric
biliary procedures.1. Case
A full-term female infant presented with persistent jaundice
(conjugated bilirubin 4.2) and acholic stools at 11 weeks of life.
Abdominal ultrasound did not identify a gallbladder or common
bile duct (CBD). Liver biopsy revealed bile duct proliferation and
ﬁbrosis consistent with biliary atresia. During operative explora-
tion, the gallbladder and CBD were found to be atretic and thus aþ1 323 361 3534.
lli@gmail.com (E.M. Pontarelli).
-NC-ND license. cholangiogram could not be performed. The liver was enlarged but
not obviously cirrhotic, so the decision was made to proceed with a
Kasai portoenterostomy and wedge liver biopsy. The ligamentous
attachments of the liver were divided to obtain complete hepatic
evisceration for better exposure. The portoenterostomy was per-
formed with an antecolic 40 cm roux-en-y jejunal limb, which is
the preferred approach of the operating surgeon because it avoids a
colonic mesenteric defect.
The initial postoperative course was uneventful, with passage of
pigmented stools on postoperative day (POD) 2. Oral pedialyte was
commenced on POD3 and advanced to standard infant formula
(Enfamil Premium, Mead Johnson Nutritionals) the following
day. Abdominal distentionwas noted at that time and an abdominal
ultrasound was performed showing a large amount of ascites. The
patient was kept on formula feeds and treated with furosemide and
aldactone with minimal improvement. Because the ascites was
refractory to diuretic therapy, a repeat ultrasound was performed
on POD10 showing an increase in the amount of abdominal ﬂuid. At
that time, the total bilirubin level had decreased from a preopera-
tive level of 9.9 to 5.1. On the 11th postoperative day, a diagnostic
paracentesis was performed to characterize the nature of the as-
cites. A total of 400 ml of milky ﬂuid was aspirated and ﬂuid
analysis revealed high triglyceride level (809 mg/dl) and 97% lym-
phocytes consistent with chylous ascites (CA). Oral feeds were held,
and the patient was started on parenteral nutrition (PN) and
octreotide (2 mg/kg/h). The abdominal distention persisted and
paracentesis was repeated on POD19, with 520 ml of chylous ﬂuid
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incrementally increased to 10 mg/kg/h, and she was kept nil per os
(NPO), which resulted in resolution of the ascites. She was dis-
charged home on POD28 with PN and octreotide.
The patient was seen in the Home TPN Clinic weekly following
discharge. Because the CA had been refractory to initial therapy, the
octreotide was decreased to 5 mg/kg/h and the patient was
permitted to drink water at her ﬁrst postdischarge visit. At 3 weeks
following discharge, the octreotide was discontinued, and she was
started on an infant formula with high medium chain triglyceride
(MCT) content (Enfaport, Mead Johnson Nutritionals). Gradually
her oral feedings were increased and the PN decreased. By 6 weeks
postdischarge she was tolerating full oral feeds with no reac-
cumulation of ascites. She was then transitioned to traditional
formula feeds by 8 weeks after discharge and has maintained
excellent biliary drainage with a normal serum bilirubin. The infant
was NPO for a total of 21 days following the diagnosis of CA, with
full recovery 77 days after diagnosis. She had no other post-
operative complications.2. Discussion
We describe a case of successful management of chylous ascites
following Kasai portoenterostomywith a treatment course of bowel
rest, PN, and octreotide followed by transition to MCT feeds. Four
other cases of chylous ascites following biliary procedures have
been reported in children, one following a Kasai [16], and three
following choledochal cyst excisions [17e19] (Table 1). Mizukami
reported spontaneous resolution of CA with no intervention [19].
This was likely a small leak which would have gone undiagnosed
without an operative drain.
The mechanism behind the formation of chylous ascites is either
traumatic disruption of lymphatic channels or obstruction of
outﬂow. In biliary procedures, CA likely results from disruption of
periportal lymphatics during the portal dissection. Hepatic lymph
comprises approximately 50% of the total body lymph ﬂow and
more than 80% of hepatic lymphatic ﬂuid drains via the periportal
lymphatics [20,21]. In procedures where the liver is mobilized, such
as transplantation and Kasai, damage to retroperitoneal lymphatics
likely contributes to a lesser degree.
Postoperative chyloperitoneum due to lymphatic channel
damage usually presents within the ﬁrst postoperative week while
obstruction due to scarringmay presentweeks tomonths later [22].
In the ﬁve cases reviewed herein, the diagnosis occurred 1e3 days
after the initiation of oral feeding, but not always in the ﬁrst post-
operative week, suggesting that damaged lymphatics with insufﬁ-
cient ﬂow remain asymptomatic.Table 1
Cases of chylous ascites following biliary surgery in children.






Current case 2 mo Kasai e 809 mg/dl 3
Hwang [16] 3 mo Kasai 200 ml/d 9.5 serum 8
Chung [17] 2 yr CC excision þ Ladds e e 4
Huang [18] 2 yr CC excision 200 ml/d 2180 mg/dl 13
Mizukami
[19]
10 mo CC excision 16 ml/d 304 mg/dl 5
CA¼ chylous ascites, CC¼ choledochal cyst, d¼ day, h¼ hour, MCT¼medium chain trigl
nutrition, yr ¼ year.Several treatment strategies for postoperative CA have been
described in the literature. Leibovitch et al. reviewed 102 articles
and proposed a treatment algorithm for postoperative and trau-
matic chylous ascites. Their approach is incremental institution of
MCT diet, PN, octreotide, and ﬁnally surgery or peritoneovenous
shunting [23]. We agree that 6e8 weeks of conservative therapy
should be completed before declaring failure. However, our
approach of early fasting combined with PN and octreotide may
decrease treatment time by avoiding periods of ineffective initial
therapy [17,18].
Infant formulas with high MCT content are available including
Enfaport (84% of fats as MCT) and Pregestimil (55% of fats as
MCT). While Hwang et al. showed eventual resolution of CA with
MCT formula and octreotide, their patient received MCT formula
alone for 3 weeks, which may explain the delay in resolution.
Furthermore, Chung et al. report failure of MCT diet and transition
to PN. Given these ﬁndings and the results from our case, we feel
that early aggressive therapy with PN, octreotide and complete
bowel rest portends to a more timely recovery.
Octreotide, a synthetic somatostatin analog, has been shown to
reduce triglyceride ﬂow from the intestine to the thoracic duct [24].
The ﬁrst reported case using octreotide to treat postoperative CA in
a child used 1e2 mg/kg/h IV for 9 days [25]. A recent review of 35
children with chylothorax described a mean octreotide infusion
rate of 3 mg/kg/h (range from 0.3 to 10 mg/kg/h) [26]. The duration of
octreotide therapy we describe herein was longer than some re-
ports. This was likely because our patient required incremental
dosage increases in order to achieve treatment effect, which took
several days. The timing of weaning the octreotide and gradual
transition to oral feeds was more conservative in our patient
because of the initial refractory nature of her ascites. Currently,
there are no standard recommendations or evidence-based guide-
lines for the dose and duration of octreotide therapy for CA with or
without oral feeding.3. Conclusions
Chylous ascites is a rare but signiﬁcant complication following
biliary procedures in children which can extend hospital stay by
1e3 weeks. A small amount of postoperative ascites is common
following Kasai and can be effectively managed with diuretics.
Marked postoperative ascites or ascites refractory to diuretic ther-
apy should be further evaluated by paracentesis. When chylous
ascites is identiﬁed, patients should be treated with bowel rest,
TPN, and octreotide, which can be titrated up to 10 mcg/kg/h until
resolution. Based on our experience with this patient and other
reports of chylous leaks octreotide should be continued for 7e14








4 TPN þ octreotide IV
10 mg/kg/h (5 weeks)
MCT formula (6 weeks) 77
10 MCT formula e failed
(3 weeks)
MCT formula þ octreotide
SQ 40 mg/kg/d (12 days)
23
7 MCT formula e failed
(1 week)
TPN (4 weeks) 28
14 TPN þ octreotide IV
6 mg/kg/h (12 days)
12
6 No treatment (3 days) 3
yceride, mo ¼month, SQ¼ subcutaneously, TG¼ triglyceride, TPN¼ total parenteral
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duration of these interventions will vary depending upon the pa-
tient’s response and may require extended treatment times.
Consent
Written informed consent was obtained from the patient for
publication of this case report. A copy of the written consent is
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